TADALAFIL | A206693 | ZYDUS PHARMACEUTICALS USA INC
Highest NADAC/Unit
$0.1582
per ea
Lowest NADAC/Unit
$0.1022
per ea
Brand NDCs
0
Generic NDCs
8
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 68382089906TADALAFIL 20 MG TABLET | $0.1582 | EA | Generic | — | 2026-08-19 |
| 68382089910TADALAFIL 20 MG TABLET | $0.1582 | EA | Generic | — | 2026-08-19 |
| 68382089806TADALAFIL 10 MG TABLET | $0.1575 | EA | Generic | — | 2026-08-19 |
| 68382089810TADALAFIL 10 MG TABLET | $0.1575 | EA | Generic | — | 2026-08-19 |
| 68382089606TADALAFIL 2.5 MG TABLET | $0.1164 | EA | Generic | — | 2026-08-19 |
| 68382089610TADALAFIL 2.5 MG TABLET | $0.1164 | EA | Generic | — | 2026-08-19 |
| 68382089706TADALAFIL 5 MG TABLET | $0.1022 | EA | Generic | — | 2026-08-19 |
| 68382089710TADALAFIL 5 MG TABLET | $0.1022 | EA | Generic | — | 2026-08-19 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.